News
Why Transocean Should Be on Your Watch List
The energy industry is facing some huge, game-changing macro trends right now, with volatile oil prices and an ever-increasing shift toward greener energy. But while green energy is taking off,....
AGTA RECORD : Consolidated third quarter sales 2017
2017 sales growth expectations of 4-5% confirmed
Group sales (1st January au 30th September)
En € million – unaudited
2017
2016
Variation
First half....
AGTA RECORD : Activité du 3ème trimestre
Prévisions annuelles confirmées : croissance de 4 à 5% du chiffre d'affaires
Chiffre d'affaires consolidé des 9 premiers mois (1er janvier au 30 septembre)
En M€ - non....
Nabors Industries Won't Restore Investor Confidence After Another Poor Quarter
2017 has been a brutal year for Nabors Industries (NYSE: NBR) stock. Sure, drilling activity hasn't been particularly robust, but the company hasn't done much to make the best of the situation as....
Gilead Slaps Mega-Price on Its Newly Approved CAR-T
Gilead Sciences (NASDAQ: GILD) recently acquired clinical-stage CAR-T drugmaker Kite Pharma, for $11.9 billion and on Wednesday, the FDA helped validate the company's purchase price by approving....
Analystenstimme: Credit Suisse sieht bei Porsche kräftiges Aufwärtspotenzial
Die Analysten der Schweizer Großbank Credit Suisse sehen bei den Aktien der Porsche SE kräftiges Aufwärtspotenzial und stufen die Papiere deshalb mit „Outperform“ ein. Wie Analyst Daniel Schwarz....
Is Seadrill LTD a Buy?
Seadrill LTD (NYSE: SDRL) announced recently that it has begun a "comprehensive restructuring," including pre-arranged Chapter 11 bankruptcy filings that will allow the company to substantially....
Amgen Wins Reprieve on Its 2nd-Best-Selling Drug
The "composition of matter" patent protecting Amgen Inc.'s (NASDAQ: AMGN) white-blood-cell-boosting drug Neulasta from competition has already expired. That may mean it's only a matter of time....
Here's Why Helix Energy Solutions Group Inc's Stock Is Surging Today
Shares of Helix Energy Solutions Group (NYSE: HLX) jumped more than 11% by 2:30 p.m. EDT on Monday. Fueling the rise was a report in The Wall Street Journal, which said that the offshore service....
Here's Why Transocean LTD Stock Was Up 26% Last Month (and Is Still Worth Buying)
September was a great month to own shares of Transocean LTD (NYSE: RIG), which gained a very strong 25.7% on the month. If we go back a couple of weeks further, Transocean's stock price jumped a....
Why Glaukos Corp. Stock Sank 12.8% in September
After management decided to dial back revenue expectations for 2017, shares of Glaukos (NYSE: GKOS), a medical device maker focused on diseases of the eye, tumbled 13% in September, according to....
This Week in Solar
The solar industry has been reeling this week, trying to decipher how each company is going to react to the "injury" fining in the Section 201 trade case, which will likely lead to tariffs on....
Why Advanced Accelerator Application SA Stock Jumped Higher Today
Shares of Advanced Accelerator Application (NASDAQ: AAAP) are up 12% as of 11:23 a.m. EDT after Bloomberg reported that Novartis (NYSE: NVS) is considering acquiring the radiopharmaceutical....
Why Aurinia Pharmaceuticals Could Be a Gold Mine for Growth Investors
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) stock has already tripled this year, on renewed hopes of success for an experimental lupus treatment. Despite this year's big run-up, this....
Why Transocean, Outfront Media, and PDL BioPharma Jumped Today
The new week began on a poor note for the stock market, as major benchmarks were broadly lower on the day. The Nasdaq Composite got hit the hardest, as big technology names took the brunt of the....
Transocean Stock History: What Investors Need to Know
Transocean (NYSE: RIG) is the world's largest offshore drilling contractor. Its rigs and employees are contracted out for drilling operations in more or less every major offshore oil-producing....
Why Intercept Pharmaceuticals, Transocean, and U.S. Steel Slumped Today
The stock market finished with small losses on Thursday, with major benchmarks falling between 0.2% and 0.5% to pull back from their recent record run. Investors are working through uncertainties....
Why Are Cancer Drugs So Expensive?
All drugs are costly to produce, but cancer drugs are notoriously expensive to push through to market, and every year, treatments get more and more expensive. In this clip from Industry Focus:....
How Much Does It Really Cost to Develop a Cancer Drug?
Cancer drugs can cost hundreds of thousands of dollars and increasing complexity suggests that prices for these drugs are going higher. For instance, Novartis (NYSE: NVS) won approval for a new....
Here's Why Glaukos Corp. Stock Is Stumbling Today
Shares of Glaukos Corp. (NYSE: GKOS), a medical device manufacturer with an eye on glaucoma, are slipping today. Just ahead of the company's investors day meeting, management made some adjustments....
Better Buy: Seadrill Partners LLC vs. Transocean LTD
Operating conditions in the offshore drilling industry have been abysmal over the past few years. While the worst appears to be over, it could be years before the sector recovers, and that's....
AGTA RECORD : First half-year results 2017
Improved profitability
Groupe key figures (January - June)
In MEUR
30.06.17
%
30.06.16
%
Variation
Turnover
175.5
100.0
166.6
100.0
+5.3%
Gross....
AGTA RECORD : Résultats semestriels 2017
Croissance de l'activité et amélioration des résultats
Chiffre d'affaires consolidé du 1er semestre (1er janvier au 30 juin)
En M€ -....
Are You Buying Gilead Sciences, Inc. for the Wrong Reason?
Gilead Sciences (NASDAQ: GILD) is up about 12% over the last week or so since Novartis (NYSE: NVS) got its chimeric antigen receptor T-cell (CAR-T) therapy Kymriah approved by the FDA.That's just....
Gilead Sciences Couldn't Have Timed its Splash Into CAR-T Better
Investors have been wondering for a few years now when Gilead Sciences (NASDAQ: GILD) would spend some of its massive cash hoard and acquire a new company, and this week, Gilead put those wonders....